Carlo Barone

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Axel Grothey, Eric Van Cutsem, Alberto Sobrero et al. · The Lancet · 2012 · 2.9K citations

Medicine, Oncology, Pharmacology +10

Prognostic Role of <i>KRAS</i> and <i>BRAF</i> in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

Arnaud Roth, Sabine Tejpar, Mauro Delorenzi et al. · Journal of Clinical Oncology · 2009 · 1.2K citations · Full text

Medicine, Oncology, Surgery +17

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

Josep Tabernero, Heinz‐Josef Lenz, Salvatore Siena et al. · The Lancet Oncology · 2015 · 326 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Some Things Never Change

Carlo Barone · Sociology of Education · 2011 · 273 citations · Full text

Education, Higher Education, Sociology +11

Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study

Jean‐Philippe Spano, Catherine Chodkiewicz, Joan Maurel et al. · The Lancet · 2008 · 249 citations

Medicine, Oncology, Pharmacology +8